Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Gene Therapy for SCID-X1 Using a Self-inactivating (SIN) Gammaretroviral Vector

NCT01175239 is registered in ClinicalTrials.gov with Great Ormond Street Hospital for Children NHS Foundation Trust as lead sponsor.

NCT NCT01175239
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01175239 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Gene Therapy for SCID-X1 Using a Self-inactivating (SIN) Gammaretroviral Vector
Lead sponsor
Great Ormond Street Hospital for Children NHS Foundation Trust
Phase
Not applicable
Overall status
Unknown status
Start date
April 30, 2011
Completion date
December 31, 2018
Enrollment
1 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

x-linked severe combined immunodeficiency